MYCOPHENILIC ACID

MYCOPHENILIC ACID was reported 21363 times

MYCOPHENILIC ACID is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CENTRAL NERVOUS SYSTEM ABSCESS 13 0.2889
1 ADENOVIRUS INTERSTITIAL NEPHRITIS 14 0.2500
2 MALACOPLAKIA 103 0.2249
3 CENTRAL NERVOUS SYSTEM LUPUS 43 0.1928
4 BACILLARY ANGIOMATOSIS 25 0.1838
5 DISSEMINATED NOCARDIOSIS 24 0.1727
6 HEART FAILURE WITH PRESERVED EJECTION FRACTION 49 0.1667
7 MALACOPLAKIA GASTROINTESTINAL 16 0.1633
8 CEREBRAL NOCARDIOSIS 37 0.1588
9 BODY MASS INDEX ABNORMAL 38 0.1557
10 ANGIOSARCOMA METASTATIC 17 0.1393
11 DISSEMINATED MUCORMYCOSIS 52 0.1320
12 MONKEYPOX 36 0.1304
13 DONOR SPECIFIC ANTIBODY PRESENT 20 0.1299
14 APOPTOSIS 40 0.1294
15 URINOMA 20 0.1266
16 RHODOCOCCUS INFECTION 21 0.1265
17 PULMONARY NOCARDIOSIS 104 0.1262
18 AMAUROSIS FUGAX 134 0.1244
19 PANCREAS TRANSPLANT REJECTION 25 0.1244
20 POLYOMAVIRUS VIRAEMIA 129 0.1215
21 CRYPTOCOCCAL CUTANEOUS INFECTION 21 0.1154
22 HUMAN EHRLICHIOSIS 24 0.1148
23 GASTROINTESTINAL MUCORMYCOSIS 19 0.1138
24 DISSEMINATED CRYPTOCOCCOSIS 86 0.1136
25 EPIDERMODYSPLASIA VERRUCIFORMIS 19 0.1131
26 BLASTOMYCOSIS 53 0.1091
27 RENAL-LIMITED THROMBOTIC MICROANGIOPATHY 25 0.1087
28 TRICHODYSPLASIA SPINULOSA 41 0.1076
29 ACANTHAMOEBA INFECTION 20 0.1064
30 VIRAL LOAD 18 0.1040
31 WEST NILE VIRAL INFECTION 78 0.1040
32 DISSEMINATED STRONGYLOIDIASIS 22 0.1005
33 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 234 0.0998
34 TRICHOPHYTOSIS 20 0.0943
35 PHAEOHYPHOMYCOSIS 45 0.0939
36 CHRONIC ALLOGRAFT NEPHROPATHY 73 0.0932
37 RENAL TRANSPLANT FAILURE 91 0.0921
38 HERPES SIMPLEX HEPATITIS 22 0.0917
39 PARVOVIRUS B19 INFECTION 80 0.0894
40 CAT SCRATCH DISEASE 35 0.0871
41 ALTERNARIA INFECTION 32 0.0860
42 DISSEMINATED MYCOBACTERIUM AVIUM COMPLEX INFECTION 19 0.0860
43 DELAYED GRAFT FUNCTION 61 0.0858
44 CYTOMEGALOVIRUS SYNDROME 14 0.0848
45 COMPLICATIONS OF TRANSPLANTED KIDNEY 189 0.0833
46 C3 GLOMERULOPATHY 17 0.0821
47 EMPHYSEMATOUS PYELONEPHRITIS 15 0.0820
48 HERPES SIMPLEX OESOPHAGITIS 15 0.0806
49 CRYPTOCOCCOSIS 129 0.0791
50 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 399 0.0783
51 SEROSITIS 42 0.0759
52 KIDNEY TRANSPLANT REJECTION 355 0.0739
53 RENAL GRAFT INFECTION 17 0.0733
54 CYSTITIS VIRAL 27 0.0705
55 DERMATOPHYTOSIS 20 0.0704
56 PULMONARY MUCORMYCOSIS 37 0.0701
57 CYTOMEGALOVIRUS OESOPHAGITIS 25 0.0679
58 UREAPLASMA INFECTION 27 0.0662
59 COMPLICATIONS OF TRANSPLANTED HEART 14 0.0651
60 CYTOMEGALOVIRUS GASTROENTERITIS 14 0.0648
61 CRYPTOSPORIDIOSIS INFECTION 34 0.0648
62 SCEDOSPORIUM INFECTION 45 0.0637
63 PNEUMONIA CRYPTOCOCCAL 59 0.0624
64 NOCARDIOSIS 155 0.0605
65 HEART TRANSPLANT REJECTION 62 0.0597
66 TRANSPLANT DYSFUNCTION 106 0.0594
67 AMERICAN TRYPANOSOMIASIS 16 0.0593
68 TRANSPLANT REJECTION 475 0.0592
69 HISTOPLASMOSIS DISSEMINATED 93 0.0586
70 INFECTION REACTIVATION 67 0.0585
71 ANAL SQUAMOUS CELL CARCINOMA 18 0.0584
72 CYTOMEGALOVIRUS VIRAEMIA 259 0.0582
73 CENTRAL NERVOUS SYSTEM FUNGAL INFECTION 13 0.0560
74 HEPATITIS E 88 0.0557
75 COMPLICATIONS OF TRANSPLANTED LUNG 17 0.0554
76 CHRONIC GRAFT VERSUS HOST DISEASE IN LIVER 20 0.0549
77 BK VIRUS INFECTION 183 0.0542
78 RENAL TUBULAR ATROPHY 47 0.0533
79 EPSTEIN-BARR VIRAEMIA 57 0.0514
80 JC VIRUS INFECTION 81 0.0506
81 ANGIOSARCOMA 23 0.0499
82 LUNG TRANSPLANT REJECTION 32 0.0485
83 MICROSPORIDIA INFECTION 17 0.0484
84 GRAFT VERSUS HOST DISEASE IN LUNG 23 0.0481
85 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 159 0.0481
86 TRANSPLANTATION COMPLICATION 20 0.0476
87 GRAFT VERSUS HOST DISEASE IN LIVER 34 0.0475
88 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 76 0.0474
89 IMMUNOGLOBULIN G4 RELATED DISEASE 15 0.0470
90 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 95 0.0446
91 MENINGITIS CRYPTOCOCCAL 78 0.0446
92 LUPUS NEPHRITIS 83 0.0443
93 VISCERAL LEISHMANIASIS 32 0.0443
94 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA 26 0.0440
95 KIDNEY FIBROSIS 76 0.0438
96 HUMAN POLYOMAVIRUS INFECTION 23 0.0433
97 STRONGYLOIDIASIS 70 0.0433
98 HUMAN HERPESVIRUS 6 INFECTION REACTIVATION 15 0.0427
99 MUCORMYCOSIS 109 0.0419
100 GRAFT VERSUS HOST DISEASE IN SKIN 92 0.0417
101 GRAFT LOSS 30 0.0414
102 PANCREATITIS HAEMORRHAGIC 19 0.0409
103 CYTOMEGALOVIRUS COLITIS 93 0.0404
104 BRAIN ABSCESS 102 0.0403
105 GLOMERULONEPHRITIS MEMBRANOPROLIFERATIVE 21 0.0401
106 CEREBRAL TOXOPLASMOSIS 36 0.0385
107 TRANSPLANT FAILURE 93 0.0379
108 EYE INFECTION TOXOPLASMAL 15 0.0378
109 LYMPHOCELE 25 0.0377
110 PERIOSTITIS 16 0.0370
111 CYTOMEGALOVIRUS INFECTION 613 0.0368
112 HUMAN HERPESVIRUS 8 INFECTION 22 0.0361
113 SMOOTH MUSCLE CELL NEOPLASM 15 0.0359
114 LIVER TRANSPLANT REJECTION 64 0.0356
115 CEREBRAL ASPERGILLOSIS 21 0.0341
116 NECROTISING OESOPHAGITIS 17 0.0341
117 ENCEPHALITIS VIRAL 39 0.0320
118 VARICELLA ZOSTER VIRUS INFECTION 66 0.0318
119 CORYNEBACTERIUM INFECTION 17 0.0318
120 ENTEROCOCCAL INFECTION 152 0.0314
121 HISTOPLASMOSIS 55 0.0310
122 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED 37 0.0308
123 URINARY TRACT DISORDER 138 0.0306
124 MUSCLE ABSCESS 19 0.0305
125 RENAL TUBULAR INJURY 37 0.0305
126 ALVEOLAR PROTEINOSIS 18 0.0304
127 ANOGENITAL WARTS 27 0.0303
128 CENTRAL NERVOUS SYSTEM LYMPHOMA 41 0.0297
129 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 42 0.0297
130 HUMAN HERPESVIRUS 6 INFECTION 56 0.0296
131 PNEUMONIA CYTOMEGALOVIRAL 57 0.0293
132 SUPERINFECTION BACTERIAL 23 0.0290
133 EPSTEIN-BARR VIRUS INFECTION 180 0.0288
134 ASPERGILLUS INFECTION 189 0.0288
135 NECROTISING RETINITIS 18 0.0281
136 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 37 0.0281
137 ENTEROVIRUS INFECTION 24 0.0278
138 MEDIASTINITIS 16 0.0276
139 GASTROENTERITIS ESCHERICHIA COLI 15 0.0274
140 METASTATIC SQUAMOUS CELL CARCINOMA 14 0.0274
141 ADENOVIRUS INFECTION 79 0.0272
142 ATYPICAL HAEMOLYTIC URAEMIC SYNDROME 22 0.0271
143 BACILLUS INFECTION 17 0.0269
144 GLOMERULOSCLEROSIS 17 0.0269
145 ENCEPHALOMALACIA 15 0.0266
146 ACINETOBACTER INFECTION 29 0.0265
147 DISSEMINATED TUBERCULOSIS 68 0.0265
148 INFECTION IN AN IMMUNOCOMPROMISED HOST 19 0.0265
149 ENTEROBACTER INFECTION 44 0.0262
150 PNEUMONIA PSEUDOMONAL 40 0.0261
151 PAPILLOMA VIRAL INFECTION 43 0.0260
152 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 195 0.0260
153 BRONCHOPULMONARY ASPERGILLOSIS 201 0.0259
154 OSMOTIC DEMYELINATION SYNDROME 19 0.0257
155 VIRAEMIA 35 0.0253
156 CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN 23 0.0248
157 RENAL TUBULAR DYSFUNCTION 14 0.0248
158 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 43 0.0243
159 GASTROENTERITIS NOROVIRUS 32 0.0241
160 KLEBSIELLA INFECTION 121 0.0239
161 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 17 0.0236
162 LISTERIOSIS 26 0.0235
163 PSEUDOMONAL BACTERAEMIA 20 0.0234
164 TRANSITIONAL CELL CARCINOMA 30 0.0231
165 VIRAL HAEMORRHAGIC CYSTITIS 16 0.0225
166 THROMBOTIC MICROANGIOPATHY 218 0.0223
167 KLEBSIELLA BACTERAEMIA 21 0.0221
168 SYSTEMIC MYCOSIS 25 0.0214
169 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 58 0.0210
170 VASOGENIC CEREBRAL OEDEMA 15 0.0208
171 TOXOPLASMOSIS 22 0.0204
172 CYTOMEGALOVIRUS INFECTION REACTIVATION 89 0.0201
173 NOROVIRUS INFECTION 29 0.0201
174 STENOTROPHOMONAS INFECTION 27 0.0199
175 PSEUDOMONAS INFECTION 167 0.0195
176 ACUTE GRAFT VERSUS HOST DISEASE 89 0.0194
177 SEPTIC EMBOLUS 16 0.0192
178 HAEMORRHAGIC STROKE 150 0.0192
179 MICROANGIOPATHIC HAEMOLYTIC ANAEMIA 15 0.0190
180 SERRATIA INFECTION 14 0.0188
181 HERPES ZOSTER DISSEMINATED 15 0.0187
182 SECONDARY IMMUNODEFICIENCY 22 0.0181
183 PYELONEPHRITIS ACUTE 35 0.0178
184 GINGIVAL HYPERTROPHY 27 0.0178
185 CHRONIC GRAFT VERSUS HOST DISEASE 64 0.0177
186 RENAL TRANSPLANT 64 0.0177
187 CYSTITIS HAEMORRHAGIC 71 0.0176
188 OBLITERATIVE BRONCHIOLITIS 23 0.0175
189 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 167 0.0175
190 APLASIA PURE RED CELL 60 0.0174
191 MYCOBACTERIAL INFECTION 30 0.0174
192 DISTRIBUTIVE SHOCK 39 0.0172
193 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 19 0.0171
194 CYTOMEGALOVIRUS CHORIORETINITIS 33 0.0169
195 FUNGAL SEPSIS 14 0.0168
196 PNEUMOCYSTIS JIROVECII PNEUMONIA 169 0.0168
197 DIFFUSE ALVEOLAR DAMAGE 19 0.0165
198 B-CELL LYMPHOMA 54 0.0159
199 CALCIPHYLAXIS 29 0.0158
200 DRUG LEVEL FLUCTUATING 14 0.0158
201 INFECTIOUS PLEURAL EFFUSION 24 0.0158
202 ESCHERICHIA INFECTION 129 0.0157
203 OESOPHAGEAL ULCER 60 0.0156
204 HEART TRANSPLANT 14 0.0155
205 LARGE INTESTINE INFECTION 19 0.0154
206 NASAL CAVITY CANCER 14 0.0153
207 SYSTEMIC INFECTION 25 0.0151
208 HYPOGAMMAGLOBULINAEMIA 99 0.0151
209 VACCINATION FAILURE 25 0.0150
210 GLOMERULONEPHRITIS 36 0.0147
211 BILIARY OBSTRUCTION 19 0.0146
212 GRAFT VERSUS HOST DISEASE 103 0.0143
213 PNEUMOPERITONEUM 26 0.0141
214 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 70 0.0140
215 ILEAL ULCER 14 0.0138
216 PNEUMONIA FUNGAL 54 0.0137
217 NEPHROPATHY TOXIC 153 0.0136
218 GENERALISED OEDEMA 166 0.0134
219 PNEUMONIA LEGIONELLA 21 0.0131
220 HAEMATOLOGICAL INFECTION 32 0.0131
221 SALMONELLOSIS 22 0.0130
222 ESCHERICHIA BACTERAEMIA 30 0.0127
223 OCULAR DISCOMFORT 143 0.0127
224 PNEUMOCYSTIS JIROVECII INFECTION 15 0.0126
225 PNEUMONIA KLEBSIELLA 23 0.0125
226 CYTOMEGALOVIRUS TEST POSITIVE 22 0.0123
227 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 13 0.0122
228 DIFFUSE LARGE B-CELL LYMPHOMA 94 0.0122
229 PNEUMOMEDIASTINUM 22 0.0122
230 HAEMOLYTIC URAEMIC SYNDROME 28 0.0121
231 STEROID DIABETES 18 0.0120
232 BACTERIAL SEPSIS 39 0.0120
233 MULTIPLE ORGAN DYSFUNCTION SYNDROME 338 0.0119
234 ACARODERMATITIS 13 0.0119
235 URINARY TRACT INFECTION BACTERIAL 30 0.0119
236 RENAL TUBULAR NECROSIS 116 0.0118
237 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 96 0.0116
238 EMPYEMA 23 0.0116
239 HERPES SIMPLEX 75 0.0115
240 MYASTHENIA GRAVIS CRISIS 17 0.0115
241 FUNGAEMIA 18 0.0114
242 MENINGITIS BACTERIAL 16 0.0112
243 HYPERPARATHYROIDISM SECONDARY 28 0.0112
244 LABELLED DRUG-DRUG INTERACTION ISSUE 16 0.0110
245 COCCIDIOIDOMYCOSIS 13 0.0109
246 OESOPHAGEAL STENOSIS 31 0.0109
247 DRUG LEVEL INCREASED 180 0.0109
248 IGA NEPHROPATHY 18 0.0108
249 SQUAMOUS CELL CARCINOMA OF SKIN 65 0.0108
250 PYELONEPHRITIS 93 0.0107
251 ESCHERICHIA SEPSIS 31 0.0107
252 LARGE INTESTINAL ULCER 29 0.0107
253 COVID-19 PNEUMONIA 126 0.0107
254 ATYPICAL MYCOBACTERIAL INFECTION 15 0.0106
255 CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY 15 0.0104
256 NORMOCYTIC ANAEMIA 15 0.0102
257 ACUTE RESPIRATORY DISTRESS SYNDROME 180 0.0102
258 DRUG LEVEL ABOVE THERAPEUTIC 46 0.0100
259 ORGANISING PNEUMONIA 49 0.0099
260 ESCHERICHIA URINARY TRACT INFECTION 41 0.0096
261 RHINOVIRUS INFECTION 37 0.0095
262 PNEUMATOSIS INTESTINALIS 27 0.0095
263 PNEUMONIA PNEUMOCOCCAL 14 0.0094
264 PROTEINURIA 178 0.0094
265 MYCOBACTERIUM AVIUM COMPLEX INFECTION 25 0.0093
266 ENCEPHALITIS 64 0.0092
267 METASTATIC MALIGNANT MELANOMA 21 0.0091
268 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 18 0.0091
269 BRAIN HERNIATION 27 0.0090
270 BACTERAEMIA 107 0.0090
271 HYDRONEPHROSIS 67 0.0089
272 GRANULOMA 30 0.0087
273 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 23 0.0086
274 LUNG CONSOLIDATION 24 0.0086
275 BRADYARRHYTHMIA 14 0.0085
276 PNEUMONIA VIRAL 27 0.0085
277 HEPATIC FIBROSIS 29 0.0084
278 PATHOGEN RESISTANCE 77 0.0084
279 CUSHINGOID 27 0.0084
280 HEAD DISCOMFORT 147 0.0083
281 HYPERVOLAEMIA 41 0.0083
282 SEPTIC SHOCK 359 0.0082
283 SOFT TISSUE INFECTION 15 0.0082
284 BLOOD IMMUNOGLOBULIN G DECREASED 20 0.0081
285 MYASTHENIA GRAVIS 65 0.0080
286 OESOPHAGEAL CANDIDIASIS 32 0.0080
287 PULMONARY ALVEOLAR HAEMORRHAGE 45 0.0080
288 CANDIDA INFECTION 135 0.0080
289 BONE EROSION 28 0.0079
290 VENOOCCLUSIVE LIVER DISEASE 39 0.0079
291 PHOTOPHOBIA 146 0.0078
292 AZOTAEMIA 31 0.0078
293 NEPHROTIC SYNDROME 53 0.0077
294 SCLERODERMA 28 0.0077
295 SYSTEMIC CANDIDA 19 0.0076
296 POSTOPERATIVE WOUND INFECTION 51 0.0075
297 ACUTE SINUSITIS 13 0.0075
298 DUODENITIS 23 0.0075
299 HAEMATURIA 255 0.0074
300 ACUTE RESPIRATORY FAILURE 142 0.0074
301 UROSEPSIS 68 0.0074
302 LYMPHOPENIA 104 0.0073
303 RENAL TUBULAR ACIDOSIS 16 0.0073
304 HEPATITIS B REACTIVATION 23 0.0072
305 HEPATIC NECROSIS 27 0.0072
306 TRANSPLANT 17 0.0072
307 OPTIC NEUROPATHY 15 0.0071
308 GENE MUTATION 14 0.0071
309 ALTERED STATE OF CONSCIOUSNESS 151 0.0070
310 FUNGAL SKIN INFECTION 28 0.0069
311 NEUROLOGICAL DECOMPENSATION 16 0.0069
312 LEUKOPENIA 343 0.0069
313 LYMPHOPROLIFERATIVE DISORDER 20 0.0068
314 END STAGE RENAL DISEASE 124 0.0068
315 GASTROINTESTINAL ULCER 15 0.0068
316 STAPHYLOCOCCAL BACTERAEMIA 29 0.0067
317 NECROTISING FASCIITIS 23 0.0065
318 NEPHROGENIC ANAEMIA 30 0.0065
319 HISTIOCYTOSIS HAEMATOPHAGIC 19 0.0064
320 ASCITES 188 0.0064
321 DERMATOMYOSITIS 16 0.0063
322 NEPHRITIS 21 0.0063
323 ABDOMINAL INFECTION 16 0.0063
324 AUTOIMMUNE HAEMOLYTIC ANAEMIA 21 0.0061
325 BRONCHIECTASIS 41 0.0061
326 CD4 LYMPHOCYTES DECREASED 13 0.0061
327 SQUAMOUS CELL CARCINOMA 57 0.0060
328 ENDOCARDITIS 31 0.0060
329 HAEMATEMESIS 153 0.0060
330 ACUTE KIDNEY INJURY 922 0.0060
331 DIPLOPIA 156 0.0060
332 VENOOCCLUSIVE DISEASE 15 0.0060
333 SKIN NECROSIS 31 0.0060
334 PRESYNCOPE 145 0.0060
335 CLOSTRIDIUM DIFFICILE COLITIS 63 0.0059
336 HAEMODYNAMIC INSTABILITY 45 0.0059
337 FUNCTIONAL GASTROINTESTINAL DISORDER 20 0.0058
338 RENAL IMPAIRMENT 483 0.0057
339 PROCTITIS 16 0.0057
340 BACTERIAL INFECTION 106 0.0057
341 NEPHROPATHY 53 0.0057
342 LUNG TRANSPLANT 20 0.0056
343 CHOLANGITIS 35 0.0056
344 ENCEPHALOPATHY 137 0.0056
345 LIVER TRANSPLANT 20 0.0055
346 RESPIRATORY FAILURE 399 0.0055
347 HAEMOLYTIC ANAEMIA 49 0.0055
348 THROMBOTIC THROMBOCYTOPENIC PURPURA 19 0.0054
349 MATERNAL EXPOSURE TIMING UNSPECIFIED 20 0.0053
350 OLIGURIA 33 0.0053
351 SKIN PAPILLOMA 21 0.0052
352 PNEUMONIA BACTERIAL 48 0.0052
353 INTRACRANIAL PRESSURE INCREASED 29 0.0052
354 BRAIN DEATH 16 0.0052
355 NEUROTOXICITY 90 0.0051
356 TUBULOINTERSTITIAL NEPHRITIS 96 0.0051
357 SEPSIS 562 0.0050
358 BLOOD CREATININE INCREASED 328 0.0050
359 PROTEIN URINE PRESENT 25 0.0050
360 PYODERMA GANGRENOSUM 18 0.0050
361 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 19 0.0050
362 LARGE INTESTINE PERFORATION 34 0.0049
363 ARTHRITIS BACTERIAL 20 0.0049
364 DRUG RESISTANCE 125 0.0049
365 ELECTROLYTE IMBALANCE 56 0.0048
366 HYPERAMMONAEMIA 24 0.0048
367 PULSELESS ELECTRICAL ACTIVITY 20 0.0048
368 HYPOVOLAEMIA 28 0.0048
369 METASTASES TO LYMPH NODES 32 0.0047
370 SHOCK HAEMORRHAGIC 38 0.0047
371 HEPATITIS CHOLESTATIC 28 0.0046
372 IMMUNOSUPPRESSION 41 0.0046
373 ANAL HAEMORRHAGE 13 0.0046
374 COMA 221 0.0046
375 DRUG INTERACTION 736 0.0046
376 BLOOD CREATININE ABNORMAL 16 0.0046
377 LIVER ABSCESS 15 0.0046
378 HYPERKALAEMIA 162 0.0046
379 COVID-19 805 0.0046
380 MYOSITIS 41 0.0046
381 FIBROSIS 14 0.0045
382 BLOOD CREATINE INCREASED 20 0.0045
383 PANCYTOPENIA 252 0.0045
384 CYTOPENIA 55 0.0045
385 STAPHYLOCOCCAL SEPSIS 22 0.0045
386 WOUND DEHISCENCE 15 0.0044
387 PAPILLOEDEMA 20 0.0044
388 CORONAVIRUS INFECTION 29 0.0044
389 ENTERITIS 28 0.0044
390 ABDOMINAL ABSCESS 19 0.0043
391 HYPERCALCAEMIA 53 0.0043
392 DUODENAL ULCER 30 0.0042
393 DISEASE RECURRENCE 201 0.0042
394 APLASTIC ANAEMIA 22 0.0042
395 BLINDNESS 171 0.0042
396 MYOPATHY 36 0.0042
397 GUILLAIN-BARRE SYNDROME 20 0.0041
398 PRE-ECLAMPSIA 19 0.0040
399 HERPES VIRUS INFECTION 23 0.0040
400 SUSPECTED OFF LABEL USE 18 0.0040
401 DISSEMINATED INTRAVASCULAR COAGULATION 56 0.0040
402 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 216 0.0039
403 ATELECTASIS 38 0.0039
404 HYPOPHOSPHATAEMIA 29 0.0039
405 LEUKOCYTOSIS 71 0.0039
406 SYSTEMIC LUPUS ERYTHEMATOSUS 139 0.0039
407 CARDIO-RESPIRATORY ARREST 159 0.0038
408 CARDIAC DYSFUNCTION 14 0.0038
409 PULMONARY MASS 56 0.0038
410 GASTROINTESTINAL TOXICITY 18 0.0037
411 MENINGITIS 25 0.0037
412 C-REACTIVE PROTEIN ABNORMAL 24 0.0037
413 SHOCK 86 0.0037
414 DISEASE COMPLICATION 17 0.0037
415 FUNGAL INFECTION 123 0.0037
416 METABOLIC ACIDOSIS 118 0.0037
417 INFLAMMATORY BOWEL DISEASE 36 0.0037
418 RESPIRATORY DISTRESS 101 0.0037
419 LOWER GASTROINTESTINAL HAEMORRHAGE 27 0.0036
420 ENTEROCOLITIS 21 0.0036
421 STAPHYLOCOCCAL INFECTION 119 0.0036
422 OESOPHAGITIS 39 0.0036
423 RESPIRATORY SYNCYTIAL VIRUS INFECTION 31 0.0036
424 TOXIC ENCEPHALOPATHY 18 0.0035
425 HEPATIC ENCEPHALOPATHY 33 0.0035
426 HAEMOLYSIS 27 0.0035
427 CLOSTRIDIUM DIFFICILE INFECTION 76 0.0035
428 FAILURE TO THRIVE 18 0.0035
429 NONSPECIFIC REACTION 19 0.0035
430 MALIGNANT MELANOMA 46 0.0034
431 CATATONIA 18 0.0034
432 GLOMERULAR FILTRATION RATE DECREASED 42 0.0034
433 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 35 0.0034
434 ACIDOSIS 26 0.0034
435 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 30 0.0034
436 SKIN INFECTION 38 0.0034
437 ABNORMAL LOSS OF WEIGHT 23 0.0034
438 ACUTE HEPATIC FAILURE 46 0.0034
439 IRON DEFICIENCY ANAEMIA 31 0.0034
440 ODYNOPHAGIA 20 0.0033
441 HYPOVOLAEMIC SHOCK 16 0.0033
442 ENDOPHTHALMITIS 20 0.0033
443 PULMONARY TUBERCULOSIS 14 0.0033
444 INTESTINAL ISCHAEMIA 18 0.0033
445 CEREBRAL ATROPHY 13 0.0033
446 ANURIA 28 0.0033
447 STREPTOCOCCAL INFECTION 18 0.0032
448 NECROSIS 18 0.0032
449 RENAL FUNCTION TEST ABNORMAL 15 0.0032
450 PULMONARY FUNCTION TEST DECREASED 14 0.0032
451 CORONARY ARTERY STENOSIS 16 0.0032
452 THERAPY NON-RESPONDER 143 0.0032
453 PEMPHIGOID 24 0.0032
454 MOUTH ULCERATION 67 0.0032
455 LUNG INFILTRATION 28 0.0032
456 BRAIN OEDEMA 40 0.0032
457 TINNITUS 145 0.0032
458 HEPATITIS B 19 0.0031
459 CARDIAC FAILURE ACUTE 21 0.0031
460 ISCHAEMIC STROKE 56 0.0031
461 PRODUCT USE IN UNAPPROVED INDICATION 773 0.0031
462 BLOOD URIC ACID INCREASED 18 0.0031
463 DIVERTICULITIS 86 0.0031
464 REBOUND EFFECT 35 0.0031
465 HYPOMAGNESAEMIA 43 0.0031
466 COLITIS 117 0.0031
467 RED BLOOD CELL SEDIMENTATION RATE INCREASED 34 0.0031
468 EYE PAIN 173 0.0031
469 RENAL CELL CARCINOMA 15 0.0031
470 GOUT 55 0.0031
471 THERAPY CHANGE 30 0.0030
472 DRUG LEVEL DECREASED 31 0.0030
473 HEPATOCELLULAR CARCINOMA 23 0.0030
474 WOUND INFECTION 33 0.0030
475 ARTERIOSCLEROSIS 28 0.0030
476 HEPATOTOXICITY 66 0.0030
477 HYPOXIA 104 0.0030
478 GASTROINTESTINAL DISORDER 263 0.0029
479 GENERALISED TONIC-CLONIC SEIZURE 48 0.0029
480 HEPATITIS C 35 0.0029
481 DIALYSIS 41 0.0029
482 OSTEOMYELITIS 52 0.0029
483 ANGIOPATHY 16 0.0029
484 MENTAL STATUS CHANGES 79 0.0028
485 PNEUMOTHORAX 45 0.0028
486 TACHYCARDIA 252 0.0028
487 NEUTROPENIA 385 0.0028
488 INFLAMMATORY MARKER INCREASED 14 0.0028
489 GASTROENTERITIS 41 0.0028
490 MYOCARDITIS 32 0.0028
491 PULMONARY FIBROSIS 53 0.0028
492 BASAL CELL CARCINOMA 43 0.0028
493 INTERSTITIAL LUNG DISEASE 131 0.0027
494 ABSCESS 43 0.0027
495 BONE MARROW FAILURE 54 0.0027
496 HEMIPARESIS 45 0.0027
497 THERAPY PARTIAL RESPONDER 41 0.0026
498 OFF LABEL USE 2300 0.0026
499 FOOD POISONING 14 0.0026
500 PNEUMONIA ASPIRATION 65 0.0026
501 SMALL INTESTINAL OBSTRUCTION 32 0.0026
502 HYPERTRANSAMINASAEMIA 18 0.0026
503 HYPOALBUMINAEMIA 20 0.0026
504 HYDROCEPHALUS 14 0.0026
505 POLYURIA 21 0.0026
506 HYPERTRIGLYCERIDAEMIA 15 0.0026
507 INFUSION SITE PAIN 33 0.0026
508 DYSLIPIDAEMIA 13 0.0026
509 TREATMENT FAILURE 211 0.0025
510 PLEURAL EFFUSION 154 0.0025
511 MUCOSAL INFLAMMATION 66 0.0025
512 SKIN LESION 69 0.0025
513 TOXICITY TO VARIOUS AGENTS 424 0.0025
514 PREMATURE DELIVERY 40 0.0025
515 HYPERGLYCAEMIA 91 0.0025
516 MATERNAL EXPOSURE BEFORE PREGNANCY 17 0.0025
517 HEPATIC FAILURE 75 0.0025
518 TRANSAMINASES INCREASED 55 0.0025
519 PERICARDIAL EFFUSION 57 0.0025
520 FACIAL PARALYSIS 21 0.0025
521 PNEUMONITIS 67 0.0025
522 URINARY TRACT INFECTION 419 0.0025
523 NEUROLOGICAL SYMPTOM 14 0.0024
524 CHRONIC KIDNEY DISEASE 186 0.0024
525 AUTOIMMUNE HEPATITIS 17 0.0024
526 CEREBRAL INFARCTION 59 0.0024
527 ATRIOVENTRICULAR BLOCK COMPLETE 16 0.0024
528 VIRAL INFECTION 79 0.0024
529 GLUCOSE TOLERANCE IMPAIRED 14 0.0024
530 CHILLS 277 0.0024
531 INFECTION 341 0.0024
532 DIARRHOEA HAEMORRHAGIC 22 0.0024
533 METASTASES TO LUNG 27 0.0023
534 VASCULITIS 27 0.0023
535 KIDNEY INFECTION 45 0.0023
536 DRUG INTOLERANCE 221 0.0023
537 PERITONITIS BACTERIAL 23 0.0023
538 MULTI-ORGAN FAILURE 39 0.0023
539 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 66 0.0023
540 SKIN MASS 15 0.0022
541 PEMPHIGUS 28 0.0022
542 CARDIOGENIC SHOCK 32 0.0022
543 PYREXIA 766 0.0022
544 HAEMATOTOXICITY 21 0.0022
545 HAEMATOMA 57 0.0022
546 HEPATITIS ACUTE 14 0.0022
547 RENAL FAILURE 286 0.0022
548 AGRANULOCYTOSIS 40 0.0021
549 RESPIRATORY TRACT INFECTION 56 0.0021
550 PERICARDITIS 36 0.0021
551 UVEITIS 29 0.0021
552 CARDIOTOXICITY 19 0.0021
553 PERITONITIS 44 0.0021
554 LUNG INFECTION 33 0.0021
555 WALKING AID USER 14 0.0021
556 TREATMENT NONCOMPLIANCE 116 0.0021
557 SENSORY LOSS 17 0.0021
558 SYNOVITIS 38 0.0021
559 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 36 0.0021
560 THERAPY INTERRUPTED 150 0.0021
561 THROMBOCYTOPENIA 234 0.0021
562 ILEUS 26 0.0021
563 PANCREATITIS ACUTE 47 0.0021
564 DEVICE RELATED INFECTION 32 0.0021
565 TACHYPNOEA 28 0.0021
566 INTESTINAL PERFORATION 23 0.0020
567 COAGULOPATHY 34 0.0020
568 BLOOD UREA INCREASED 34 0.0020
569 LARGE INTESTINE POLYP 14 0.0020
570 QUALITY OF LIFE DECREASED 27 0.0020
571 LACTIC ACIDOSIS 65 0.0020
572 GASTRIC ULCER 38 0.0020
573 CYTOKINE RELEASE SYNDROME 40 0.0020
574 OSTEOPOROSIS 82 0.0020
575 C-REACTIVE PROTEIN INCREASED 72 0.0020
576 OSTEOPENIA 30 0.0020
577 ORAL CANDIDIASIS 26 0.0020
578 IMMUNE SYSTEM DISORDER 26 0.0020
579 PULMONARY HYPERTENSION 41 0.0020
580 CENTRAL NERVOUS SYSTEM LESION 27 0.0020
581 UPPER GASTROINTESTINAL HAEMORRHAGE 33 0.0020
582 ULCER 31 0.0019
583 DRUG-INDUCED LIVER INJURY 61 0.0019
584 MITRAL VALVE INCOMPETENCE 22 0.0019
585 PNEUMONIA 628 0.0019
586 HYPERBILIRUBINAEMIA 20 0.0019
587 ABDOMINAL PAIN 447 0.0019
588 HYPOTONIA 19 0.0019
589 ANAEMIA 362 0.0019
590 GASTROINTESTINAL INFECTION 17 0.0019
591 BLOOD LACTATE DEHYDROGENASE INCREASED 30 0.0019
592 MATERNAL EXPOSURE DURING PREGNANCY 168 0.0019
593 BLOOD SODIUM DECREASED 35 0.0019
594 HELICOBACTER INFECTION 19 0.0018
595 CHOLECYSTITIS 22 0.0018
596 VITAMIN D DEFICIENCY 18 0.0018
597 FEBRILE NEUTROPENIA 122 0.0018
598 INTERNAL HAEMORRHAGE 21 0.0018
599 COELIAC DISEASE 18 0.0018
600 BLOOD PRESSURE INCREASED 280 0.0018
601 DIVERTICULUM 13 0.0018
602 HERPES ZOSTER 105 0.0018
603 GASTRITIS 48 0.0018
604 SKIN ULCER 47 0.0018
605 CARDIAC ARREST 150 0.0018
606 ACUTE CORONARY SYNDROME 15 0.0018
607 PULMONARY OEDEMA 81 0.0018
608 SUPRAVENTRICULAR TACHYCARDIA 17 0.0018
609 CONDITION AGGRAVATED 539 0.0018
610 RENAL DISORDER 82 0.0018
611 UPPER RESPIRATORY TRACT INFECTION 81 0.0018
612 DYSPNOEA EXERTIONAL 66 0.0018
613 ASPIRATION 19 0.0017
614 DIABETES MELLITUS 132 0.0017
615 SYNCOPE 173 0.0017
616 LYMPHADENOPATHY 61 0.0017
617 DIARRHOEA 1110 0.0017
618 FLUID OVERLOAD 25 0.0017
619 PRODUCTIVE COUGH 82 0.0017
620 URINE OUTPUT DECREASED 15 0.0017
621 LUNG DISORDER 84 0.0017
622 PARALYSIS 24 0.0017
623 HYPONATRAEMIA 94 0.0017
624 INFLAMMATION 86 0.0017
625 DIABETIC KETOACIDOSIS 40 0.0017
626 DISEASE PROGRESSION 197 0.0017
627 INFUSION SITE ERYTHEMA 14 0.0017
628 METASTASES TO LIVER 29 0.0016
629 HIDRADENITIS 15 0.0016
630 AUTOIMMUNE DISORDER 16 0.0016
631 HAEMORRHOIDS 32 0.0016
632 ORAL HERPES 32 0.0016
633 SCIATICA 26 0.0016
634 LIVER INJURY 40 0.0016
635 CHOLESTASIS 31 0.0016
636 DELIRIUM 56 0.0016
637 COUGH 452 0.0016
638 APPENDICITIS 15 0.0016
639 EYELID PTOSIS 16 0.0016
640 ABORTION SPONTANEOUS 63 0.0016
641 CELLULITIS 79 0.0016
642 ADRENAL INSUFFICIENCY 19 0.0016
643 HEPATIC CIRRHOSIS 29 0.0015
644 HAEMOPTYSIS 43 0.0015
645 BLOOD POTASSIUM INCREASED 25 0.0015
646 VISION BLURRED 209 0.0015
647 INTENTIONAL PRODUCT USE ISSUE 133 0.0015
648 ABDOMINAL PAIN UPPER 312 0.0015
649 STATUS EPILEPTICUS 17 0.0015
650 DYSURIA 55 0.0015
651 BLOOD PRESSURE FLUCTUATION 35 0.0015
652 MYALGIA 247 0.0015
653 OXYGEN SATURATION DECREASED 81 0.0014
654 SKIN CANCER 31 0.0014
655 APHONIA 20 0.0014
656 DERMATITIS 30 0.0014
657 MALNUTRITION 16 0.0014
658 BLOOD TEST ABNORMAL 20 0.0014
659 FISTULA 16 0.0014
660 HYPERLIPIDAEMIA 17 0.0014
661 IMMUNODEFICIENCY 21 0.0014
662 HYPOPHAGIA 36 0.0014
663 INTENTIONAL DOSE OMISSION 40 0.0014
664 CONTRAINDICATED PRODUCT ADMINISTERED 42 0.0014
665 FLUID RETENTION 70 0.0014
666 HOSPITALISATION 211 0.0014
667 IMPAIRED HEALING 45 0.0014
668 SPLENOMEGALY 16 0.0014
669 HYPOKALAEMIA 63 0.0014
670 CYSTITIS 43 0.0013
671 HAEMOGLOBIN DECREASED 138 0.0013
672 TENDERNESS 14 0.0013
673 FOLLICULITIS 14 0.0013
674 BLOOD PRESSURE SYSTOLIC INCREASED 26 0.0013
675 GASTROENTERITIS VIRAL 24 0.0013
676 SOMNOLENCE 267 0.0013
677 DECREASED APPETITE 306 0.0013
678 GASTROOESOPHAGEAL REFLUX DISEASE 106 0.0013
679 MYELODYSPLASTIC SYNDROME 19 0.0013
680 EOSINOPHILIA 23 0.0013
681 INSURANCE ISSUE 20 0.0013
682 POST PROCEDURAL COMPLICATION 25 0.0013
683 MASS 18 0.0013
684 CARDIOMYOPATHY 19 0.0013
685 ACUTE MYELOID LEUKAEMIA 20 0.0013
686 HALLUCINATION, VISUAL 27 0.0013
687 SECRETION DISCHARGE 16 0.0013
688 BRAIN FOG 20 0.0013
689 LIVER FUNCTION TEST ABNORMAL 37 0.0013
690 CARDIAC FAILURE 102 0.0013
691 GENERAL PHYSICAL HEALTH DETERIORATION 147 0.0013
692 MUSCLE ATROPHY 16 0.0013
693 CATARACT 75 0.0013
694 HEPATITIS 32 0.0012
695 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 60 0.0012
696 DEHYDRATION 166 0.0012
697 VOMITING 585 0.0012
698 PULMONARY ARTERIAL HYPERTENSION 18 0.0012
699 LOCALISED INFECTION 30 0.0012
700 BLOOD BILIRUBIN INCREASED 33 0.0012
701 MYELOSUPPRESSION 43 0.0012
702 ABDOMINAL PAIN LOWER 30 0.0012
703 GASTROINTESTINAL HAEMORRHAGE 99 0.0012
704 DRUG INEFFECTIVE 1556 0.0012
705 OEDEMA 64 0.0012
706 BLOOD IRON DECREASED 14 0.0012
707 NIGHT SWEATS 38 0.0012
708 INFLUENZA 131 0.0012
709 PRODUCT DOSE OMISSION IN ERROR 33 0.0012
710 HYPOCALCAEMIA 22 0.0012
711 BLOOD URINE PRESENT 22 0.0012
712 HYPERTENSION 245 0.0012
713 BURSITIS 14 0.0012
714 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 82 0.0012
715 PHOTOSENSITIVITY REACTION 19 0.0011
716 AMENORRHOEA 20 0.0011
717 THERAPEUTIC RESPONSE DECREASED 69 0.0011
718 BLINDNESS UNILATERAL 16 0.0011
719 OEDEMA PERIPHERAL 138 0.0011
720 WEIGHT DECREASED 316 0.0011
721 DIABETES MELLITUS INADEQUATE CONTROL 20 0.0011
722 OSTEONECROSIS 37 0.0011
723 APHASIA 34 0.0011
724 SURGERY 66 0.0011
725 ASTHENIA 422 0.0011
726 CEREBRAL HAEMORRHAGE 40 0.0011
727 HYPOTENSION 224 0.0011
728 DYSPNOEA 621 0.0011
729 INTRAOCULAR PRESSURE INCREASED 14 0.0011
730 VENTRICULAR TACHYCARDIA 18 0.0011
731 RENAL FAILURE ACUTE 46 0.0011
732 RENAL INJURY 32 0.0011
733 TREMOR 178 0.0011
734 HEPATIC ENZYME INCREASED 73 0.0011
735 ATRIAL FIBRILLATION 104 0.0011
736 OBESITY 17 0.0011
737 LIVER DISORDER 47 0.0011
738 PERIPHERAL SWELLING 163 0.0011
739 INFUSION RELATED REACTION 70 0.0011
740 ABDOMINAL DISCOMFORT 176 0.0010
741 URINARY RETENTION 35 0.0010
742 UNRESPONSIVE TO STIMULI 27 0.0010
743 HEADACHE 650 0.0010
744 METASTASES TO BONE 17 0.0010
745 RASH MACULO-PAPULAR 23 0.0010
746 PREMATURE BABY 31 0.0010
747 LIVER FUNCTION TEST INCREASED 22 0.0010
748 NAUSEA 803 0.0010
749 SKIN HAEMORRHAGE 15 0.0010
750 PRODUCT PRESCRIBING ISSUE 22 0.0010
751 MELAENA 22 0.0010
752 MUSCULAR WEAKNESS 113 0.0010
753 THERAPY CESSATION 51 0.0010
754 HEPATIC FUNCTION ABNORMAL 37 0.0010
755 SEASONAL ALLERGY 14 0.0010
756 SINUSITIS 101 0.0010
757 RASH ERYTHEMATOUS 47 0.0010
758 BODY TEMPERATURE INCREASED 20 0.0010
759 HIP ARTHROPLASTY 15 0.0010
760 LYMPHOMA 15 0.0010
761 RESPIRATORY DISORDER 29 0.0010
762 HEPATIC STEATOSIS 18 0.0010
763 DELUSION 15 0.0010
764 INTESTINAL OBSTRUCTION 36 0.0010
765 PRESCRIBED UNDERDOSE 19 0.0010
766 PSORIATIC ARTHROPATHY 38 0.0009
767 DEPRESSED LEVEL OF CONSCIOUSNESS 37 0.0009
768 HERNIA 18 0.0009
769 NERVOUS SYSTEM DISORDER 29 0.0009
770 JAUNDICE 25 0.0009
771 EXPOSURE DURING PREGNANCY 57 0.0009
772 RED BLOOD CELL COUNT DECREASED 26 0.0009
773 SEIZURE 105 0.0009
774 PANCREATITIS 48 0.0009
775 ANGINA PECTORIS 26 0.0009
776 FALL 298 0.0009
777 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 23 0.0009
778 RASH PAPULAR 20 0.0009
779 FATIGUE 693 0.0009
780 TRANSIENT ISCHAEMIC ATTACK 30 0.0009
781 INSOMNIA 236 0.0009
782 BLOOD ALKALINE PHOSPHATASE INCREASED 22 0.0009
783 PULMONARY EMBOLISM 84 0.0009
784 DISORIENTATION 35 0.0009
785 PRODUCT PRESCRIBING ERROR 21 0.0009
786 ALANINE AMINOTRANSFERASE INCREASED 54 0.0009
787 PRODUCT USE ISSUE 165 0.0009
788 SCAR 15 0.0009
789 DYSPHAGIA 83 0.0009
790 COLITIS ULCERATIVE 39 0.0009
791 GAIT INABILITY 29 0.0009
792 ARTHRALGIA 360 0.0009
793 BLOOD POTASSIUM DECREASED 26 0.0009
794 DEEP VEIN THROMBOSIS 56 0.0009
795 THROMBOSIS 69 0.0009
796 LOWER RESPIRATORY TRACT INFECTION 39 0.0009
797 ABDOMINAL DISTENSION 89 0.0009
798 LYMPHOCYTE COUNT DECREASED 15 0.0008
799 LABORATORY TEST ABNORMAL 25 0.0008
800 DEATH 723 0.0008
801 INCREASED APPETITE 16 0.0008
802 SWELLING 78 0.0008
803 GLAUCOMA 16 0.0008
804 BRADYCARDIA 44 0.0008
805 JOINT SWELLING 100 0.0008
806 CORONARY ARTERY DISEASE 25 0.0008
807 FIBROMYALGIA 20 0.0008
808 ACUTE MYOCARDIAL INFARCTION 24 0.0008
809 HAEMORRHAGE 85 0.0008
810 PSYCHOTIC DISORDER 24 0.0008
811 LIMB INJURY 22 0.0008
812 LIMB DISCOMFORT 25 0.0008
813 ORTHOSTATIC HYPOTENSION 14 0.0008
814 JOINT STIFFNESS 21 0.0008
815 NEUROPATHY PERIPHERAL 76 0.0008
816 ILLNESS 82 0.0008
817 PRODUCT DOSE OMISSION ISSUE 233 0.0008
818 MALAISE 347 0.0008
819 RHINORRHOEA 51 0.0008
820 SLEEP APNOEA SYNDROME 15 0.0008
821 EPILEPSY 24 0.0008
822 DYSPEPSIA 77 0.0008
823 THROAT IRRITATION 35 0.0008
824 PLATELET COUNT DECREASED 82 0.0008
825 WEIGHT INCREASED 171 0.0008
826 ANHEDONIA 20 0.0008
827 HEART RATE INCREASED 75 0.0008
828 WOUND 21 0.0008
829 BRONCHITIS 55 0.0007
830 ANAPHYLACTIC REACTION 41 0.0007
831 WHEEZING 44 0.0007
832 PAIN IN JAW 21 0.0007
833 NEPHROLITHIASIS 34 0.0007
834 WHITE BLOOD CELL COUNT DECREASED 80 0.0007
835 OROPHARYNGEAL PAIN 68 0.0007
836 DIZZINESS 366 0.0007
837 PRURITUS 279 0.0007
838 MOBILITY DECREASED 52 0.0007
839 GAMMA-GLUTAMYLTRANSFERASE INCREASED 16 0.0007
840 ARTHRITIS 56 0.0007
841 EPISTAXIS 53 0.0007
842 HAEMATOCHEZIA 39 0.0007
843 MUSCULOSKELETAL PAIN 37 0.0007
844 BLOOD PRESSURE ABNORMAL 14 0.0007
845 CHEST DISCOMFORT 72 0.0007
846 LOSS OF CONSCIOUSNESS 90 0.0007
847 IRRITABLE BOWEL SYNDROME 15 0.0007
848 SWELLING FACE 45 0.0007
849 DISCOMFORT 42 0.0007
850 NASAL CONGESTION 40 0.0007
851 RIB FRACTURE 14 0.0007
852 EAR INFECTION 18 0.0007
853 UNDERDOSE 49 0.0007
854 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 120 0.0007
855 HYPERSOMNIA 19 0.0007
856 STOMATITIS 40 0.0007
857 NEOPLASM MALIGNANT 44 0.0007
858 ASPARTATE AMINOTRANSFERASE INCREASED 35 0.0007
859 CARDIAC DISORDER 61 0.0007
860 RECTAL HAEMORRHAGE 28 0.0007
861 DEAFNESS 17 0.0006
862 BLOOD PRESSURE DECREASED 43 0.0006
863 NASOPHARYNGITIS 119 0.0006
864 BLOOD CHOLESTEROL INCREASED 30 0.0006
865 DEPRESSED MOOD 34 0.0006
866 PLASMA CELL MYELOMA 25 0.0006
867 CHEST PAIN 118 0.0006
868 ARTHROPATHY 35 0.0006
869 THERAPEUTIC PRODUCT EFFECT DECREASED 28 0.0006
870 CHROMATURIA 14 0.0006
871 FEMUR FRACTURE 19 0.0006
872 ADVERSE DRUG REACTION 55 0.0006
873 ANGIOEDEMA 27 0.0006
874 SKIN DISCOLOURATION 28 0.0006
875 LETHARGY 35 0.0006
876 NECK PAIN 34 0.0006
877 URINARY INCONTINENCE 18 0.0006
878 COGNITIVE DISORDER 28 0.0006
879 WHITE BLOOD CELL COUNT INCREASED 23 0.0006
880 CEREBROVASCULAR ACCIDENT 101 0.0006
881 ARRHYTHMIA 28 0.0006
882 BLOOD CREATINE PHOSPHOKINASE INCREASED 17 0.0006
883 OSTEOARTHRITIS 25 0.0006
884 BLISTER 33 0.0006
885 DYSARTHRIA 22 0.0006
886 DYSPHONIA 34 0.0006
887 POLLAKIURIA 24 0.0006
888 CONFUSIONAL STATE 93 0.0006
889 MUSCULOSKELETAL STIFFNESS 50 0.0006
890 SKIN DISORDER 19 0.0006
891 INTERNATIONAL NORMALISED RATIO INCREASED 16 0.0006
892 GASTRIC DISORDER 19 0.0006
893 RASH PRURITIC 30 0.0006
894 SPEECH DISORDER 29 0.0006
895 SLEEP DISORDER 39 0.0006
896 CHOLELITHIASIS 18 0.0005
897 ILL-DEFINED DISORDER 33 0.0005
898 DRY MOUTH 44 0.0005
899 CONTUSION 52 0.0005
900 LUNG NEOPLASM MALIGNANT 22 0.0005
901 THERAPEUTIC RESPONSE UNEXPECTED 24 0.0005
902 ACCIDENTAL OVERDOSE 19 0.0005
903 UNEVALUABLE EVENT 39 0.0005
904 ALOPECIA 101 0.0005
905 BACK PAIN 119 0.0005
906 RASH 223 0.0005
907 FLATULENCE 29 0.0005
908 FOETAL EXPOSURE DURING PREGNANCY 41 0.0005
909 PAIN IN EXTREMITY 148 0.0005
910 DERMATITIS ATOPIC 26 0.0005
911 GAIT DISTURBANCE 94 0.0005
912 RHEUMATOID ARTHRITIS 55 0.0005
913 VISUAL IMPAIRMENT 60 0.0005
914 HEART RATE DECREASED 17 0.0005
915 TYPE 2 DIABETES MELLITUS 16 0.0005
916 MIGRAINE 45 0.0005
917 DISTURBANCE IN ATTENTION 25 0.0005
918 INFLUENZA LIKE ILLNESS 38 0.0005
919 PALPITATIONS 54 0.0005
920 MENTAL DISORDER 20 0.0005
921 RASH MACULAR 16 0.0005
922 FEELING HOT 28 0.0005
923 HYPOAESTHESIA 67 0.0004
924 SUICIDE ATTEMPT 27 0.0004
925 DYSSTASIA 13 0.0004
926 OCULAR HYPERAEMIA 21 0.0004
927 BLOOD GLUCOSE INCREASED 82 0.0004
928 HYPOGLYCAEMIA 21 0.0004
929 RHABDOMYOLYSIS 18 0.0004
930 VERTIGO 26 0.0004
931 CONSTIPATION 93 0.0004
932 PARAESTHESIA 67 0.0004
933 NO ADVERSE EVENT 77 0.0004
934 PAIN 261 0.0004
935 DRY EYE 21 0.0004
936 MUSCLE SPASMS 77 0.0004
937 MYOCARDIAL INFARCTION 73 0.0004
938 BURNING SENSATION 29 0.0004
939 CARDIAC FAILURE CONGESTIVE 33 0.0004
940 NEOPLASM PROGRESSION 14 0.0004
941 ECZEMA 21 0.0004
942 HYPERSENSITIVITY 74 0.0004
943 ROAD TRAFFIC ACCIDENT 16 0.0004
944 FEELING ABNORMAL 91 0.0004
945 EYE SWELLING 14 0.0004
946 URTICARIA 62 0.0004
947 ADVERSE EVENT 34 0.0004
948 AMNESIA 24 0.0004
949 AGITATION 27 0.0004
950 PRODUCT SUBSTITUTION ISSUE 21 0.0004
951 DYSGEUSIA 27 0.0004
952 ELECTROCARDIOGRAM QT PROLONGED 13 0.0004
953 MEMORY IMPAIRMENT 48 0.0003
954 BALANCE DISORDER 30 0.0003
955 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 16 0.0003
956 ASTHMA 38 0.0003
957 DEPRESSION 76 0.0003
958 ERYTHEMA 68 0.0003
959 ANXIETY 94 0.0003
960 PSORIASIS 43 0.0003
961 INJURY 23 0.0003
962 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 17 0.0003
963 FLUSHING 33 0.0003
964 HALLUCINATION 23 0.0003
965 INJECTION SITE BRUISING 24 0.0003
966 AGGRESSION 15 0.0003
967 IRRITABILITY 18 0.0003
968 CONVULSION 17 0.0003
969 SKIN EXFOLIATION 24 0.0003
970 EYE IRRITATION 16 0.0003
971 ACNE 21 0.0003
972 HOT FLUSH 20 0.0003
973 INTENTIONAL OVERDOSE 17 0.0003
974 HYPERHIDROSIS 34 0.0003
975 DRY SKIN 35 0.0003
976 EMOTIONAL DISTRESS 31 0.0003
977 PRODUCT STORAGE ERROR 21 0.0002
978 INJECTION SITE HAEMORRHAGE 19 0.0002
979 DEVICE ISSUE 21 0.0002
980 BONE PAIN 13 0.0002
981 SUICIDAL IDEATION 20 0.0002
982 INJECTION SITE REACTION 15 0.0002
983 INCORRECT DOSE ADMINISTERED 49 0.0002
984 INJECTION SITE SWELLING 16 0.0002
985 OVERDOSE 43 0.0002
986 PROSTATE CANCER 16 0.0002
987 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 40 0.0002
988 MALIGNANT NEOPLASM PROGRESSION 20 0.0002
989 INJECTION SITE PAIN 53 0.0002
990 ACCIDENTAL EXPOSURE TO PRODUCT 17 0.0002
991 BREAST CANCER 14 0.0002
992 INJECTION SITE ERYTHEMA 15 0.0001